Literature DB >> 20404416

Organic and inorganic dietary phosphorus and its management in chronic kidney disease.

Nazanin Noori1, John J Sims, Joel D Kopple, Anuja Shah, Sara Colman, Christian S Shinaberger, Rachelle Bross, Rajnish Mehrotra, Csaba P Kovesdy, Kamyar Kalantar-Zadeh.   

Abstract

Dietary phosphorus control is often a main strategy in the management of patients with chronic kidney disease. Dietary protein is a major source of phosphorus intake. Recent data indicate that imposed dietary phosphorus restriction may compromise the need for adequate protein intake, leading to protein-energy wasting and possibly to increased mortality. The two main sources of dietary phosphorus are organic, including animal and vegetarian proteins, and inorganic, mostly food preservatives. Animal-based foods and plant are abundant in organic phosphorus. Usually 40% to 60% of animal-based phosphorus is absorbed; this varies by degree of gastrointestinal vitamin-D-receptor activation, whereas plant phosphorus, mostly associated with phytates, is less absorbable by human gastrointestinal tract. Up to 100% of inorganic phosphorus in processed foods may be absorbed; ie, phosphorus in processed cheese and some soda (cola) drinks. A recent study suggests that a higher dietary phosphorus-protein intake ratio is associated with incremental death risk in patients on long-term hemodialysis. Hence, for phosphorus management in chronic kidney disease, in addition to absolute dietary phosphorus content, the chemical structure (inorganic versus organic), type (animal versus plant), and phosphorus-protein ratio should be considered. We recommend foods and supplements with no or lowest quantity of inorganic phosphorus additives, more plant-based proteins, and a dietary phosphorus-protein ratio of less than 10 mg/g. Fresh (nonprocessed) egg white (phosphorus-protein ratio less than 2 mg/g) is a good example of desirable food, which contains a high proportion of essential amino acids with low amounts of fat, cholesterol, and phosphorus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404416

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  33 in total

1.  Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study.

Authors:  Lynn M Taylor; Kamyar Kalantar-Zadeh; Theodore Markewich; Sara Colman; Debbie Benner; John J Sim; Csaba P Kovesdy
Journal:  J Ren Care       Date:  2011-03

2.  Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.

Authors:  Cristina Garagarza; Ana Valente; Cristina Caetano; Telma Oliveira; Pedro Ponce; Ana Paula Silva
Journal:  Int Urol Nephrol       Date:  2017-03-06       Impact factor: 2.370

Review 3.  Phosphate Toxicity in CKD: The Killer among Us.

Authors:  Cynthia S Ritter; Eduardo Slatopolsky
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-10       Impact factor: 8.237

4.  Acute tumoral calcinosis due to severe hyperphosphatemia in a maintenance hemodialysis patient.

Authors:  Keizo Nishime; Hiroki Takahashi
Journal:  CEN Case Rep       Date:  2016-06-24

Review 5.  Management of phosphorus load in CKD patients.

Authors:  Yutaka Taketani; Fumihiko Koiwa; Keitaro Yokoyama
Journal:  Clin Exp Nephrol       Date:  2016-11-28       Impact factor: 2.801

Review 6.  Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.

Authors:  Csaba P Kovesdy; Leigh Darryl Quarles
Journal:  Nephrol Dial Transplant       Date:  2013-04-25       Impact factor: 5.992

7.  Design and development of a dialysis food frequency questionnaire.

Authors:  Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Rachelle Bross; Debbie Benner; Nazanin Noori; Sameer B Murali; Torin Block; Jean Norris; Joel D Kopple; Gladys Block
Journal:  J Ren Nutr       Date:  2010-09-15       Impact factor: 3.655

8.  Developmental Changes in Phosphate Homeostasis.

Authors:  Tate MacDonald; Matthew Saurette; Megan R Beggs; R Todd Alexander
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

9.  Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.

Authors:  Karl Eckberg; Holly Kramer; Myles Wolf; Ramon Durazo-Arvizu; Bamidele Tayo; Amy Luke; Richard Cooper
Journal:  Nephrol Dial Transplant       Date:  2014-10-30       Impact factor: 5.992

10.  Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.

Authors:  Meei Wah Chan; Huey Miin Cheah; Madihah Binti Mohd Padzil
Journal:  Int J Clin Pharm       Date:  2019-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.